Rational methods for the selection of diverse screening compounds.

Traditionally a pursuit of large pharmaceutical companies, high-throughput screening assays are becoming increasingly common within academic and government laboratories. This shift has been instrumental in enabling projects that have not been commercially viable, such as chemical probe discovery and screening against high-risk targets. Once an assay has been prepared and validated, it must be fed with screening compounds. Crafting a successful collection of small molecules for screening poses a significant challenge. An optimized collection will minimize false positives while maximizing hit rates of compounds that are amenable to lead generation and optimization. Without due consideration of the relevant protein targets and the downstream screening assays, compound filtering and selection can fail to explore the great extent of chemical diversity and eschew valuable novelty. Herein, we discuss the different factors to be considered and methods that may be employed when assembling a structurally diverse compound collection for screening. Rational methods for selecting diverse chemical libraries are essential for their effective use in high-throughput screens.We are grateful for financial support from the MRC, Wellcome Trust, CRUK, EPSRC, BBSRC and Newman Trust.This is the author accepted manuscript. The final version is available from American Chemical Society via http://dx.doi.org/10.1021/cb100420

In silico activity and ADMET profiling of phytochemicals from Ethiopian indigenous aloes using pharmacophore models

In silico profiling is used in identification of active compounds and guide rational use of traditional medicines. Previous studies on Ethiopian indigenous aloes focused on documentation of phytochemical compositions and traditional uses. In this study, ADMET and drug-likeness properties of phytochemicals from Ethiopian indigenous aloes were evaluated, and pharmacophore-based profiling was done using Discovery Studio to predict therapeutic targets. The targets were examined using KEGG pathway, gene ontology and network analysis. Using random-walk with restart algorithm, network propagation was performed in CODA network to find diseases associated with the targets. As a result, 82 human targets were predicted and found to be involved in several molecular functions and biological processes. The targets also were linked to various cancers and diseases of immune system, metabolism, neurological system, musculoskeletal system, digestive system, hematologic, infectious, mouth and dental, and congenital disorder of metabolism. 207 KEGG pathways were enriched with the targets, and the main pathways were metabolism of steroid hormone biosynthesis, lipid and atherosclerosis, chemical carcinogenesis, and pathways in cancer. In conclusion, in silico target fishing and network analysis revealed therapeutic activities of the phytochemicals, demonstrating that Ethiopian indigenous aloes exhibit polypharmacology effects on numerous genes and signaling pathways linked to many diseases

Data-driven approaches used for compound library design, hit triage and bioactivity modeling in high-throughput screening

High-throughput screening (HTS) campaigns are routinely performed in pharmaceutical companies to explore activity profiles of chemical libraries for the identification of promising candidates for further investigation. With the aim of improving hit rates in these campaigns, data-driven approaches have been used to design relevant compound screening collections, enable effective hit triage and perform activity modeling for compound prioritization. Remarkable progress has been made in the activity modeling area since the recent introduction of large-scale bioactivity-based compound similarity metrics. This is evidenced by increased hit rates in iterative screening strategies and novel insights into compound mode of action obtained through activity modeling. Here, we provide an overview of the developments in data-driven approaches, elaborate on novel activity modeling techniques and screening paradigms explored and outline their significance in HTS.Medicinal Chemistr

Design and implementation of a platform for predicting pharmacological properties of molecules

Tese de mestrado, Bioinformática e Biologia Computacional, Universidade de Lisboa, Faculdade de Ciências, 2019O processo de descoberta e desenvolvimento de novos medicamentos prolonga-se por vários anos e implica o gasto de imensos recursos monetários. Como tal, vários métodos in silico são aplicados com o intuito de dimiuir os custos e tornar o processo mais eficiente. Estes métodos incluem triagem virtual, um processo pelo qual vastas coleções de compostos são examinadas para encontrar potencial terapêutico. QSAR (Quantitative Structure Activity Relationship) é uma das tecnologias utilizada em triagem virtual e em optimização de potencial farmacológico, em que a informação estrutural de ligandos conhecidos do alvo terapêutico é utilizada para prever a actividade biológica de um novo composto para com o alvo. Vários investigadores desenvolvem modelos de aprendizagem automática de QSAR para múltiplos alvos terapêuticos. Mas o seu uso está dependente do acesso aos mesmos e da facilidade em ter os modelos funcionais, o que pode ser complexo quando existem várias dependências ou quando o ambiente de desenvolvimento difere bastante do ambiente em que é usado. A aplicação ao qual este documento se refere foi desenvolvida para lidar com esta questão. Esta é uma plataforma centralizada onde investigadores podem aceder a vários modelos de QSAR, podendo testar os seus datasets para uma multitude de alvos terapêuticos. A aplicação permite usar identificadores moleculares como SMILES e InChI, e gere a sua integração em descritores moleculares para usar como input nos modelos. A plataforma pode ser acedida através de uma aplicação web com interface gráfica desenvolvida com o pacote Shiny para R e directamente através de uma REST API desenvolvida com o pacote flask-restful para Python. Toda a aplicação está modularizada através de teconologia de “contentores”, especificamente o Docker. O objectivo desta plataforma é divulgar o acesso aos modelos criados pela comunidade, condensando-os num só local e removendo a necessidade do utilizador de instalar ou parametrizar qualquer tipo de software. Fomentando assim o desenvolvimento de conhecimento e facilitando o processo de investigação.The drug discovery and design process is expensive, time-consuming and resource-intensive. Various in silico methods are used to make the process more efficient and productive. Methods such as Virtual Screening often take advantage of QSAR machine learning models to more easily pinpoint the most promising drug candidates, from large pools of compounds. QSAR, which means Quantitative Structure Activity Relationship, is a ligand-based method where structural information of known ligands of a specific target is used to predict the biological activity of another molecule against that target. They are also used to improve upon an existing molecule’s pharmacologic potential by elucidating the structural composition with desirable properties. Several researchers create and develop QSAR machine learning models for a variety of different therapeutic targets. However, their use is limited by lack of access to said models. Beyond access, there are often difficulties in using published software given the need to manage dependencies and replicating the development environment. To address this issue, the application documented here was designed and developed. In this centralized platform, researchers can access several QSAR machine learning models and test their own datasets for interaction with various therapeutic targets. The platform allows the use of widespread molecule identifiers as input, such as SMILES and InChI, handling the necessary integration into the appropriate molecular descriptors to be used in the model. The platform can be accessed through a Web Application with a full graphical user interface developed with the R package Shiny and through a REST API developed with the Flask Restful package for Python. The complete application is packaged up in container technology, specifically Docker. The main goal of this platform is to grant widespread access to the QSAR models developed by the scientific community, by concentrating them in a single location and removing the user’s need to install or set up software unfamiliar to them. This intends to incite knowledge creation and facilitate the research process

Identification of Novel Antimalarial Chemotypes via Chemoinformatic Compound Selection Methods for a High-Throughput Screening Program against the Novel Malarial Target, PfNDH2: Increasing Hit Rate via Virtual Screening Methods

Malaria is responsible for approximately 1 million deaths annually; thus, continued efforts to discover new antimalarials are required. A HTS screen was established to identify novel inhibitors of the parasite's mitochondrial enzyme NADH:quinone oxidoreductase (PfNDH2). On the basis of only one known inhibitor of this enzyme, the challenge was to discover novel inhibitors of PfNDH2 with diverse chemical scaffolds. To this end, using a range of ligand-based chemoinformatics methods, ~17000 compounds were selected from a commercial library of ~750000 compounds. Forty-eight compounds were identified with PfNDH2 enzyme inhibition IC(50) values ranging from 100 nM to 40 μM and also displayed exciting whole cell antimalarial activity. These novel inhibitors were identified through sampling 16% of the available chemical space, while only screening 2% of the library. This study confirms the added value of using multiple ligand-based chemoinformatic approaches and has successfully identified novel distinct chemotypes primed for development as new agents against malaria

Recent advances in in silico target fishing

In silico target fishing, whose aim is to identify possible protein targets for a query molecule, is an emerging approach used in drug discovery due its wide variety of applications. This strategy allows the clarification of mechanism of action and biological activities of compounds whose target is still unknown. Moreover, target fishing can be employed for the identification of off targets of drug candidates, thus recognizing and preventing their possible adverse effects. For these reasons, target fishing has increasingly become a key approach for polypharmacology, drug repurposing, and the identification of new drug targets. While experimental target fishing can be lengthy and difficult to implement, due to the plethora of interactions that may occur for a single small-molecule with different protein targets, an in silico approach can be quicker, less expensive, more efficient for specific protein structures, and thus easier to employ. Moreover, the possibility to use it in combination with docking and virtual screening studies, as well as the increasing number of web-based tools that have been recently developed, make target fishing a more appealing method for drug discovery. It is especially worth underlining the increasing implementation of machine learning in this field, both as a main target fishing approach and as a further development of already applied strategies. This review reports on the main in silico target fishing strategies, belonging to both ligand-based and receptor-based approaches, developed and applied in the last years, with a particular attention to the different web tools freely accessible by the scientific community for performing target fishing studies